Long-term effect of hepatocyte growth factor in the normal lung: A stereological assessment

A. Leuenberger, L. Knudsen, A. Gazdhar, T. Geiser, M. Ochs (Bern, Switzerland; Hannover, Germany)

Source: Annual Congress 2011 - Growth factors and fibrogenesis: are they good, bad or both?
Session: Growth factors and fibrogenesis: are they good, bad or both?
Session type: Oral Presentation
Number: 3235
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Leuenberger, L. Knudsen, A. Gazdhar, T. Geiser, M. Ochs (Bern, Switzerland; Hannover, Germany). Long-term effect of hepatocyte growth factor in the normal lung: A stereological assessment. Eur Respir J 2011; 38: Suppl. 55, 3235

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Changes and significance of hepatoma-derived growth factor and vascular endothelial growth factor in serum and lung tissue from patients with lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010

Overexpression of fibroblast growth factor and down-regulation of platelet-derived growth factor correlate with advanced-stage lung fibrosis
Source: Annual Congress 2010 - Cell biology and immunology of lung disease
Year: 2010


Human hepatocyte growth factor levels in patients undergoing thoracic operations
Source: Eur Respir J 2006; 27: 73-76
Year: 2006



Nerve growth factor levels and localisation in human asthmatic bronchi
Source: Eur Respir J 2002; 20: 1110-1116
Year: 2002



Keratinocyte growth factor (rHuKGF) increases surfactant protein A in rats and prevents alveolar oedema after orthotopic rat lung transplantation
Source: Eur Respir J 2006; 28: Suppl. 50, 779s
Year: 2006

Expression and role of the nerve growth factor NGF in pulmonary hypertension
Source: Annual Congress 2011 - Pathobiology of experimental pulmonary hypertension
Year: 2011

Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) as a prognostic factor of survival in patients with lung adenocarcinoma
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008


Serum levels of insulin-like growth factor binding protein-3 and vascular endothelial growth factor in obstructivesleep apnea patients. Effect of CPAP treatment
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012

Antifibrotic role of hepatocyte growth factor (HGF) in fibrosing interstial lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 367s
Year: 2001

Increased expression of angiogenic growth factor stromal cell derived factor-1 (SDF-1/CXCL12) in pleural fluid of patients with lung cancer: preliminary results
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008

Synergistic effect of cysteinyl-leukotrienes and epidermal growth factor on human lung fibroblast mitogenesis
Source: Eur Respir J 2005; 26: Suppl. 49, 340s
Year: 2005

Keratinocyte growth factor prevents intra-alveolar oedema in experimental lung isografts
Source: Eur Respir J 2008; 31: 21-28
Year: 2008



Genetic profiling and epidermal growth factor receptor-directed therapy in nonsmall cell lung cancer
Source: Eur Respir J 2011; 37: 183-193
Year: 2011



Down regulation of human insulin-like growth factor in lung tissue of patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 574s
Year: 2007

Insulin-like growth factor binding protein-3 induction by transforming growth factor-β1 mediates differentiation of a myofibroblast phenotype in human lung fibroblasts
Source: Eur Respir J 2003; 22: Suppl. 45, 7s
Year: 2003

Keratinocyte growth factor improves alterations of lung permeability and bronchial epithelium in allergic rats
Source: Eur Respir J 2007; 30: 31-39
Year: 2007



Cell specific gene transfer of hepatocyte growth factor reduces bleomycin-induced lung fibrosis by inhibition of partial EMT
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008

Epidermal growth factor in the lungs of infants developing chronic lung disease
Source: Eur Respir J 2001; 18: 796-800
Year: 2001



Detection of epidermal growth factor receptor mutation in plasma as predictor of gefitinib response in non small cell lung cancer
Source: Annual Congress 2008 - Therapy in thoracic oncology
Year: 2008



Hepatocyte growth factor prevents airway remodelling in asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 194s
Year: 2003